I4337 2 mg (Terazosin Hydrochloride 2 mg)
Pill with imprint I4337 2 mg is White & Yellow, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Teva Pharmaceuticals USA.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I4337 2 mg
Terazosin Hydrochloride
- Imprint
- I4337 2 mg
- Strength
- 2 mg
- Color
- White & Yellow
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-4337 (Discontinued)
- Inactive Ingredients
-
corn starch,
crospovidone,
D&C Yellow No. 10,
aluminum oxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
gelatin,
lactose monohydrate,
magnesium stearate,
propylene glycol,
shellac,
ferrosoferric oxide,
magnesium silicate,
titanium dioxide,
D&C Red No. 33
Note: Inactive ingredients may vary.
More about terazosin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (48)
- Drug images
- Pricing & coupons
- En español
- Drug class: alpha-adrenoreceptor antagonists
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.